Laurie J. Hall Trustee’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Laurie J. Hall Trustee’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-85	Closed	-$1K	–	335
2022 Q4	$1K	Sell	85 -45	-35%	-$637	﹤0.01%	307
2022 Q3	$2K	Buy	130 +40	+44%	+$644	﹤0.01%	303
2022 Q2	$1K	Hold	90	–	–	﹤0.01%	316
2022 Q1	$1K	Hold	90	–	–	﹤0.01%	321
2021 Q4	$1K	Hold	90	–	–	﹤0.01%	323
2021 Q3	$1K	Sell	90 -50	-36%	-$800	﹤0.01%	325
2021 Q2	$3K	Hold	140	–	–	﹤0.01%	316
2021 Q1	$3K	Hold	140	–	–	﹤0.01%	322
2020 Q4	$3K	Hold	140	–	–	﹤0.01%	317
2020 Q3	$6K	Buy	+140	New	+$6.43K	﹤0.01%	288
2019 Q4	$12K	Buy	100 +20	+25%	+$1.79K	0.01%	270
2019 Q3	$5K	Buy	80 +30	+60%	+$2.02K	﹤0.01%	290
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	307
2019 Q1	$6K	Hold	50	–	–	﹤0.01%	297
2018 Q4	$6K	Sell	50 -10	-17%	-$1.04K	﹤0.01%	298
2018 Q3	$8K	Hold	60	–	–	﹤0.01%	308
2018 Q2	$5K	Hold	60	–	–	﹤0.01%	326
2018 Q1	$4K	Hold	60	–	–	﹤0.01%	332
2017 Q4	$4K	Buy	+60	New	+$3.78K	﹤0.01%	334

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Laurie J. Hall Trustee's ICPT Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 85 shares — an estimated $1K sold.

Laurie J. Hall Trustee first reported a position in ICPT in Q4 2017 and held it in 19 quarters. The position peaked at $12K in Q4 2019. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

Laurie J. Hall Trustee reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Laurie J. Hall Trustee sold 85 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1K.
Laurie J. Hall Trustee first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 19 quarters.
Laurie J. Hall Trustee's Intercept Pharmaceuticals, Inc. position peaked at $12K in Q4 2019.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.